Tuesday, December 20, 2016

Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis - Journal of Antibiotics

Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis

The Journal of Antibiotics 69, 879 (December 2016). doi:10.1038/ja.2016.45

Authors: Shasha Rao, Clive A Prestidge, Lynn Miesel, Deb Sweeney, Dean L Shinabarger & Ramiz A Boulos



from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/1XlK60I
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)